Clinical trial
Linking Elexacaftor/Tezacaftor/Ivacaftor to Infections in Cystic Fibrosis Lung Disease
NCT05675592 is registered in ClinicalTrials.gov with Ospedale San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Linking Elexacaftor/Tezacaftor/Ivacaftor to Infections in Cystic Fibrosis Lung Disease
- Lead sponsor
- Ospedale San Raffaele
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 22, 2022
- Completion date
- May 16, 2025
- Enrollment
- 20 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.